BioPharmaDispatch discusses the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies with Better Access Australia co-founder and chair Felicity McNeill.We discuss the recommendations, the lack of any overarching objective and what the raft of proposed processes and reviews actually mean.